Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome).

R Dummer, M Duvic, J Scarisbrick, E A Olsen, S Rozati, N Eggmann, S M Goldinger, K Hutchinson, L Geskin, T M Illidge, E Giuliano, J Elder, Y H Kim

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome).'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science